Thor Medical ASA (OB: TRMED)
Health Care · Biotechnology · NO
Nkr4.46
-1.00% today · +27.7% 1Y
Thor Medical ASA (OB: TRMED) operates in the Biotechnology industry within the Health Care sector. The company is valued at $196.75M and employs 24 people.
Over the last twelve months the share price has gained 27.7%, trading between 3.31 and 7.12.
Tweenvest scores Thor Medical ASA across four factors: quality 59/100, value 42/100. Its strongest factor is quality.
TRMED price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $196.75M
- Revenue (TTM)
- $165.46K
- P/E
- —
- EPS
- -0.23
- Dividend yield
- —
- Beta (5Y)
- -0.01
- 52-week high
- Nkr7.12
- 52-week low
- Nkr3.31
- Avg volume (3M)
- —
- Shares outstanding
- 422.50M
- Employees
- 24
- Next earnings
- —
About Thor Medical ASA
Established in 2017, Thor Medical ASA, with its headquarters in Oslo, Norway, specializes in the development and provision of alpha-particle emitters for oncology treatments within Norway.
- ISIN
- NO0010597883
- Founded
- 2009
- Listed since
- Mar 23, 2015
- Exchange
- Oslo Bors
- Currency
- NOK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cue Biopharma, Inc.NasdaqCM: CUE | $200.93M | $27.66 | +23.87% |
| Whitehawk Therapeutics, Inc.NasdaqCM: WHWK | $200.67M | $3.52 | -4.86% |
| S.Biomedics Co., Ltd.KOSDAQ: A304360 | $200.37M | ₩21,750.00 | +4.07% |
| Alpha Cognition Inc.NasdaqCM: ACOG | $196.87M | $9.04 | -0.66% |
| IntoCell, Inc.KOSDAQ: A287840 | $193.53M | ₩17,320.00 | -4.04% |
| Precision BioSciences, Inc.NasdaqCM: DTIL | $185.48M | $6.72 | +4.51% |
| Adagene Inc.NasdaqGM: ADAG | $185.32M | $2.76 | -3.16% |
| PepGen Inc.NasdaqGS: PEPG | $181.46M | $2.62 | +10.08% |
Figures last refreshed Oct 11, 2026.